Skip to main content
. 2022 Feb;66:None. doi: 10.1016/j.cbpa.2021.07.001

Table 1.

Discussed approaches and their characteristics.

Strategy Method Invasiveness Labeling time Enrichment Multiplexing Degradation analysis Spatial resolution Reference
Puromycin-based PUNCH-P 15 min + No −− [10]
OPP 2 h + No −− [11]
OPP-pSILAC 2 h + No −− [12]
QOT + 15 min + Yes −− [13]
BONCAT-based AHA/HPG ++ Hrs/days + No + −− [17]
ANL Days (in vivo) + No + + [43, 44, 45, 46∗]
QuaNCAT ++ 2–4 h + No + −− [23]
MITNCAT ++ 15 min + Yes + −− [40]
HILAQ ++ 1 h ++ No + −− [24]
PhosID ++ 4–24 h ++ No + −− [37]
SILAC-based Dynamic SILAC +++ 6 h/days N/A No ++ −− [47,48]
mPDP +++ 3–48 h N/A Yes ++ −− [50]
MePROD +++ 2 h N/A Yes ++ −− [49]

QOT, quantitative OPP tagging; MITNCAT, multiplex isobaric tagging/noncanonical amino acid tagging; HILAQ, heavy isotope-labeled AHA quantification; mPDP, multiplexed proteome dynamics profiling; MePROD, multiplexed enhanced protein dynamics.

Beneficial attributes are represented with ‘+’, whereas limitations are indicated as ‘−’. ‘Invasiveness’ describes the adverse effect of the technique on the system under investigation.